Uncertainty Looms After Hexo Reports Decent Earnings

Here’s why investors seem to be hesitant with Hexo (TSX:HEXO)(NYSE:HEXO) right now.

| More on:

Hexo (TSX:HEXO)(NYSE:HEXO) is a company I think remains a great play on the domestic Canadian cannabis market. Hexo’s recently reported decent earnings, and investors may be excited about its existing business.

However, its recent acquisitions paint a different picture.

It now appears this company is trying to push to become a global player. As it is currently still a relatively small player in the global cannabis space, this is a good thing. There’s a race to the top, and Hexo seems willing to look at expanding in prudent ways.

That said, this space is a volatile one. Accordingly, it appears some investors feel there’s too much uncertainty with this stock right now.

Hexo’s decent earnings call is worth a second look

Hexo’s recent earnings certainly provide investors with what looks like pretty decent long-term upside. The company reported total net revenue of $32.9 million this past quarter. This was up from $17 million from the prior-year quarter.

That’s some decent revenue growth.

Additionally, this past quarter marked the seventh consecutive quarter where the firm reported positive adjusted EBITDA. Not only that, but the firm also noted that non-beverage adult-use revenue increase by 6% amid growing beverage-based adult-use sales.

Net revenue of adult-use cannabis products also marked the fifth consecutive quarter of improvement. This has helped Hexo to maintain the lead market share position in Quebec’s cannabis market. Revenue for the rest of Canada increased by 49%, signaling the company isn’t just a tiny regional player any more.

These earnings are a testament to this company’s long-term potential. Indeed, investors will continue to be looking at the company’s high-margin products to see how profitable Hexo will be long term.

Foreign growth a key for investors

While the earnings call paints a promising picture, investors seem to be worried about the company’s global expansion potential. Hexo still isn’t a company with direct access to the U.S. market like other Canadian-listed peers. Additionally, despite impressive revenue growth, this firm’s financial position leaves something more to desire.

As of a month ago, Hexo had no real presence in the U.S. market. The firm has heavily focused on improving its foothold in the domestic market and is just starting to build its foreign brand strategy.

Hexo has placed its bets on Charles Bowman, who was recently inducted as the general manager of U.S. operations, and Rose Marie Gage, chair of director board. They are supposed to contribute with their extensive experience in operations to improve Hexo’s market presence in the U.S.

However, until more progress is made, many investors may continue to sit on the sidelines.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »